The Washington-based biotech is focusing on upcoming label expansions and its promising pipeline.
Aera Therapeutics emerged from stealth mode Thursday with a platform based on the work of Feng Zhang, Ph.D. and ex-Alnylam executive Akin Akinc at the helm.
Through the job cuts and other cost-saving measures, Grifols aims to save approximately $428 million USD in 2023, relative to comparative full-year 2022 costs, according to the company.
However, Labcorp’s forecast is steeper than that of its closest rival Quest, which sees COVID sales declining by as much as 88% this year.
ReutersThe vote puts the naloxone-based treatment Narcan on track to potentially become the first opioid overdose drug to be sold OTC nationwide.
The U.S. National Institutes of Health (NIH) said on Wednesday that it had started a clinical trial to evaluate Japan’s Shionogi & Co. Ltd.’s experimental oral antiviral drug to treat COVID-19.
The European Medicines Agency (EMA) expects COVID vaccination campaigns to be conducted once a year, similar to the approach with flu inoculation, it said on Wednesday.
Bausch + Lomb Corp. on Wednesday named Brent Saunders, the former chief executive officer of Allergan, as its CEO and chairman of board, marking his return to the Canadian eye-care company after nearly a decade.
Biogen Inc. (BIIB.O) Chief Executive Officer Christopher Viehbacher said on Wednesday he is banking on high-profile launches of Alzheimer’s disease treatment Leqembi and depression drug zuranolone, as well as deals, to help the company return to revenue growth.
Avian flu has reached new corners of the globe and become endemic for the first time in some wild birds that transmit the virus to poultry, according to veterinarians and disease experts, who warn it is now a year-round problem.
